Angelini Ventures
Headquarter
Strasbourg, France
Milestones
Founded: 2025
(Built and supported by Argobio)
Invested: 2025
CO-Founder and CEO
Delphine Charvin
Vertical
Biotech
Board Participation
Fabrizio Calisti, Board Member
Operator of an antidepressant treatment development firm intended to transform the treatment of mental health disorders. The company specializes in developing a safe, well-tolerated, and effective antidepressant therapy for depression, advancing psychiatric treatments, and developing a neuroplastogen, enabling patients to rediscover the pleasures of life and significantly reduce the risks of suicide and relapse.
Related news: